eczema
MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain
December 16, 2024LEO Pharma, eczema
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …
UC San Diego School of Medicine researchers treat atopic dermatitis with bacteriotherapy
February 24, 2021Research and Development atopic dermatitis, eczema
Researchers at the University of California San Diego School of Medicine have identified a universal strain of bacteria derived from …
LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema
November 2, 2020Research and Development, Sales and Marketing LEO Pharma, eczema, pharma
LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema
March 25, 2020Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment
Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
Atopic dermatitis market set to almost triple in value over next 10 years
December 12, 2018Research and Development atopic dermatitis, eczema, global data, markets, money
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market …
Novartis buys eczema drug in €95m deal
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent
Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …
NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds
April 4, 2018Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma
UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …
Novartis acquires Ziarco adding to dermatology pipeline
December 19, 2016Sales and Marketing Novartis, Ziarco, eczema, oral
Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …
Pfizer’s next blockbuster given FDA approval
December 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema
Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
Pfizer announces strong Phase III results for atopic dermatitis drug
July 14, 2016Research and Development Pfizer, anacor, atopic dermatitis, crisaborole, eczema
Pfizer (NYSE: PFE) has announced positive results from two pivotal Phase III studies for crisaborole in the treatment of mild …
Featured Market Report: Atopic Dermatitis (eczema) Forecast in 17 Major Markets
December 7, 2015Manufacturing and Production, Research and Development Black Swan, eczema
Featured Market Report: Forecast Report on Atopic Dermatitis (eczema) in 17 Major Markets Black Swan’s report on Atopic Dermatitis, also …
Genus reprimanded for ‘sexual and titillating’ advert
August 15, 2012Sales and Marketing ABPI, Genus, PMCPA, breach, eczema
Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …
Digital Pharma: Byte-sized roundup
November 20, 2009Medical Communications LinkedIn, digi, digital pharma, eczema, electronic patient records, patients
LinkedIn and Microsoft have signed a deal that will see the forthcoming version of Outlook incorporate feeds from the social networking platform.The …
